Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 307

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 307
---
 equity subscription agreement (the “PIPE Equity Subscription Agreement”) with one accredited investor (the “PIPE Investor”) pursuant to which the PIPE Investor has committed to purchase 1,500,000shares of ParentCo Common Stock at a purchase price per share of $ 10.00(the “PIPE Shares”), for an aggregate purchase price of $ 15,000,000(the “PIPE Equity Investment”). The obligations to consummate the transaction

<div align='center'>F-84</div>

contemplated by the PIPE Equity Subscription Agreement are conditioned upon, among other things, customary closing conditions and the consummation of the transactions contemplated by the Business Combination Agreement. On July 19, 2024, the parties to the Business Combination Agreement amended the Business Combination Agreement to extend the date by which the parties thereto can terminate the Business Combination Agreement, which was September 3, 2024. On July 23, 2024, the PIPE Equity Subscription Agreement was amended to increase the PIPE Investor’s committed purchase of PIPE Shares from 1,500,000to 2,500,000, increase the PIPE Equity Investment from $ 15,000,000to $ 25,000,000, and extend the date by which the PIPE Investor can terminate the agreement to September 3, 2024. On August 16, 2024, the parties to the Business Combination Agreement amended the Business Combination Agreement (the “Fifth Amendment”) to extend the date by which the parties thereto can terminate the Business Combination Agreement, which is December 31, 2024. On October 23, 2024, the parties to the Business Combination Agreement amended the Business Combination Agreement to amend the consideration to be paid in the Transactions to consist of 17.5million shares of ParentCo’s common stock at $ 10per share value. On October 31, 2024, the PIPE Equity Subscription Agreement was amended to decrease the PIPE Investor’s committed purchase of PIPE Shares from 2,500,000to 1,500,000, and decrease the PIPE Equity Investment from $ 25,000,000to $ 15,000,000. On December 26, 2024, the parties to the Business Combination Agreement amended the Business Combination Agreement to extend the date by which the parties thereto can terminate the Business Combination Agreement to June 30, 2025. On December 26, 2024, the parties amended the date by which the PIPE Investor can terminate the agreement to June